257 related articles for article (PubMed ID: 31599385)
1. Long-term oncological results after transanal total mesorectal excision for rectal carcinoma.
Hol JC; van Oostendorp SE; Tuynman JB; Sietses C
Tech Coloproctol; 2019 Sep; 23(9):903-911. PubMed ID: 31599385
[TBL] [Abstract][Full Text] [Related]
2. Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer.
Caycedo-Marulanda A; Lee L; Chadi SA; Verschoor CP; Crosina J; Ashamalla S; Brown CJ;
JAMA Netw Open; 2021 Feb; 4(2):e2036330. PubMed ID: 33533932
[TBL] [Abstract][Full Text] [Related]
3. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
[TBL] [Abstract][Full Text] [Related]
4. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
[TBL] [Abstract][Full Text] [Related]
5. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
[TBL] [Abstract][Full Text] [Related]
6. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
[No Abstract] [Full Text] [Related]
7. Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME.
Chen YT; Kiu KT; Yen MH; Chang TC
Asian J Surg; 2019 Jun; 42(6):674-680. PubMed ID: 30318319
[TBL] [Abstract][Full Text] [Related]
8. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
9. Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short- and mid-term results.
Muratore A; Mellano A; Marsanic P; De Simone M
Eur J Surg Oncol; 2015 Apr; 41(4):478-83. PubMed ID: 25633642
[TBL] [Abstract][Full Text] [Related]
10. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
[TBL] [Abstract][Full Text] [Related]
11. Transanal total mesorectal excision: 3-year oncological outcomes.
Ourô S; Albergaria D; Ferreira MP; Costeira B; Roquete P; Ferreira D; Maio R
Tech Coloproctol; 2021 Feb; 25(2):205-213. PubMed ID: 33113009
[TBL] [Abstract][Full Text] [Related]
12. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients.
Mege D; Hain E; Lakkis Z; Maggiori L; Prost À la Denise J; Panis Y
Colorectal Dis; 2018 Jun; 20(6):O143-O151. PubMed ID: 29693307
[TBL] [Abstract][Full Text] [Related]
13. Transanal mesorectal excision: early outcomes in Australia and New Zealand.
Lau S; Kong J; Bell S; Heriot A; Stevenson A; Moloney J; Hayes J; Merrie A; Eglinton T; Guest G; Clark D; Warrier S
Br J Surg; 2021 Mar; 108(2):214-219. PubMed ID: 33711138
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
[TBL] [Abstract][Full Text] [Related]
15. Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer.
Dittrich L; Biebl M; Schmuck R; Gül S; Weiss S; Haase O; Knoop M; Alkatout I; Pratschke J; Aigner F
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33379270
[TBL] [Abstract][Full Text] [Related]
16. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries.
Perdawood SK; Thinggaard BS; Bjoern MX
Surg Endosc; 2018 May; 32(5):2312-2321. PubMed ID: 29098433
[TBL] [Abstract][Full Text] [Related]
17. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
[No Abstract] [Full Text] [Related]
18. Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients.
Burke JP; Martin-Perez B; Khan A; Nassif G; de Beche-Adams T; Larach SW; Albert MR; Atallah S
Colorectal Dis; 2016 Jun; 18(6):570-7. PubMed ID: 26749148
[TBL] [Abstract][Full Text] [Related]
19. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
[TBL] [Abstract][Full Text] [Related]
20. Transanal total mesorectal excision for stage II or III rectal cancer: pattern of local recurrence in a tertiary referral center.
González-Abós C; de Lacy FB; Guzmán Y; Nogueira ST; Otero-Piñeiro A; Almenara R; Lacy AM
Surg Endosc; 2021 Dec; 35(12):7191-7199. PubMed ID: 33398553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
